mo:re provides a laboratory platform that automates the planning, culture, and analysis of complex 3D cell culture models. The platform is designed to deliver verifiable, standardized results without requiring expertise in specific organ systems. Led by CEO Lukas Gaats, the company focuses on complex cell culture workflows and commercialization of its system. mo:re raised €2.3M in Seed funding to accelerate commercialization of its platform. The funding will be used to speed the commercialization of the platform for complex cell culture workflows. The company is based in Hamburg, Germany.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Mar 2025